USPTO serial 90524944
Serial No. 90524944
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 26, 2025
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 90524944?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Connie L. Ellerbach
Connie L. Ellerbach FENWICK & WEST LLP801 CALIFORNIA STREETMOUNTAIN VIEW, CA 94041United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; vaccine preparations; medical preparations for the treatment of infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, namely, infectious diseases, respiratory diseases, mucosal diseases, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for, infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, tumors, and cancer | ACTIVE | — |
| 010 | Medical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, namely, automatic vaccination apparatus | ACTIVE | — |
| 042 | Research and development of vaccines; research and development of medicines, namely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 26, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 7, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 7, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 3, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 29, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jun 29, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 28, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 13, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 13, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 20, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 21, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 19, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 19, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 19, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 20, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 20, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 21, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 21, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 28, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 3, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 3, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 25, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 25, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 25, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 15, 2021 | NWAP | NEW APPLICATION ENTERED | — |